ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0024 • ACR Convergence 2021

    Heterogeneity of Inflammatory HLA-DR+ Synovial Fibroblasts in Rheumatoid Arthritis Is Driven by Responses to Leukocyte-Derived Cytokines

    Melanie Smith1, Alejandro Kochen1, Vianne Gao2, Michail Schizas2, Edward DiCarlo1, Susan Goodman1, Christina Leslie3, Laura Donlin1 and Alexander Rudensky4, 1Hospital for Special Surgery, New York, NY, 2Memorial Sloan Kettering Cancer Center, New York, NY, 3Computational and Systems Biology Program Memorial Sloan Kettering Cancer Center, New York, NY, 4Memorial Sloan Kettering Cancer Center / Howard Hughes Medical Institute, New York, NY

    Background/Purpose: Treatment-refractory rheumatoid arthritis (RA) represents a major unmet need with substantial societal burden. Targeting RA-associated fibroblast-like synoviocytes (FLS) may provide a less-immunosuppressive therapeutic option.…
  • Abstract Number: 0023 • ACR Convergence 2021

    Investigating Temporal Changes in Pregnancy Among Women with Rheumatoid Arthritis and Healthy Women Using Co-expression Network Analysis

    Matthew Wright1, Dana Goin2, Mette Smed3, J Lee Nelson4, Nicholas Jewell5, Jorn Olsen6, Merete Hetland7, Vibeke Zoffmann3 and Damini Jawaheer8, 1UCSF Benioff Children's Hospital Oakland, Oakland, CA, 2University of California San Francisco, San Francisco, CA, 3Juliane Marie Center, Rigshospitalet, Copenhagen, Denmark, 4Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, 5University of California Berkeley, Berkeley, CA, 6Aarhus University Hospital, Aarhus, Denmark, 7DANBIO and COPECARE, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, 8UCSF Benioff Children's Hospital Oakland / University of California San Francisco, Oakland, CA

    Background/Purpose: Rheumatoid arthritis (RA), while still an incurable disease, can often improve naturally during pregnancy. The specific mechanism(s) underlying this pregnancy-induced improvement, however, are not…
  • Abstract Number: 0026 • ACR Convergence 2021

    Synovial Fibroblasts Acquire a Proinflammatory and Destructive Phenotype After Exposure to αS1-Casein (CSN1S1)

    Nadine Honke1, Tim Appel1, Matthias Schneider2 and Georg Pongratz3, 1Department of Rheumatology, Hiller Research Center Rheumatology, University Hospital Düsseldorf, Germany (* contributed equally), Düsseldorf, Germany, 2Policlinic & Hiller Research Unit Rheumatology, UKD, Heinrich-Heine University, Düsseldorf, Germany, 3Polyclinic and Functional Area for Rheumatology & Hiller Research Center Rheumatology, University Hospital Düsseldorf, Düsseldorf, Germany

    Background/Purpose: The milk protein αS1-Casein (CSN1S1) was described to be overexpressed in synovial tissue of patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Recently we…
  • Abstract Number: 0029 • ACR Convergence 2021

    JAK1 Regulates Autophagy and Reinforces the Inflammatory and Autoimmune Potentials in Rheumatoid Arthritis Synovial Fibroblasts

    Keita Ninagawa1, Masaru Kato1, Yuki Kudo2, Masaru Yoshimura2, Michihito Kono2, Yuichiro Fujieda1, Kenji Oku2 and Tatsuya Atsumi3, 1Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 21. Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 3Hokkaido University, Sapporo, Japan

    Background/Purpose: Rheumatoid arthritis (RA) is pathologically characterized by autoimmunity against citrullinated proteins, proliferative synovitis, and ultimately joint destruction. Synovial fibroblasts (SFs) are, when activated, capable…
  • Abstract Number: 0028 • ACR Convergence 2021

    Evolution of Anti-modified Protein Antibody Responses Can Be Driven by Consecutive Exposure to Different Post-translational Modifications

    Mikhail Volkov, Arieke Kampstra, Karin van Schie, Tom WJ Huizinga, René Toes and Diane van der Woude, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Besides anti-citrullinated protein antibodies (ACPA), rheumatoid arthritis patients (RA) often display autoantibody reactivities against other post-translationally modified (PTM) proteins, more specifically carbamylated and acetylated…
  • Abstract Number: 0027 • ACR Convergence 2021

    Metabolomic Study of Rheumatoid Arthritis Using 1H Nuclear Magnetic Resonance (1H NMR)

    Konstantina Tsezou, Dimitra Benaki, Katerina iliou, Emmanuel Mikros and Panayiotis Vlachoyiannopoulos, National and Kapodistrian University of Athens, Athens, Greece

    Background/Purpose: Rheumatoid arthritis (RA) remains a disease with high morbidity. Biologic agents revolutionized the therapy of RA, but they are withdrawn in 50% of patients…
  • Abstract Number: 0022 • ACR Convergence 2021

    The Effects of MAA-Modified and/or Citrullinated Proteins on Calcium Influx and Peptidyl Arginine Deiminase (PAD) Expression in Macrophage

    Andrew Gerber, Michael Duryee, Nozima Aripova, Bryant England, James O'Dell, Ted Mikuls and Geoffrey Thiele, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Expressed in synovial fluid mononuclear and other inflammatory cells, peptidyl arginine deiminase (PAD) catalyzes post-translational citrullination of synovial proteins in a calcium (Ca2+)-dependent manner.…
  • Abstract Number: 0033 • ACR Convergence 2021

    Impaired Adipose Tissue Function in Rheumatoid Arthritis: Association with Autoimmunity, Disease Activity and Therapeutic Response

    Iván Arias de la Rosa1, alejandro Escudero2, Cristobal Román-Rodriguez2, Rocio Guzmán-Ruiz2, Maria del Mar Malagón2, Carlos Pérez-Sánchez3, Chamaida Plasencia-Rodríguez4, Ana Martinez-Feito5, Maria del Carmen Ábalos-Aguilera2, Alejandra Patiño-Trives6, Jerusalem Calvo2, Rafaela Ortega2, Eduardo Collantes-Estevez2, Chary Lopez-Pedrera2 and Nuria Barbarroja1, 1University of Cordoba/IMIBIC/Reina Sofia Hospital, Cordoba, Spain, 2IMIBIC/Reina Sofia Hospital/University of Córdoba, Córdoba, Spain, 3IMIBIC, Córdoba, Spain, 4Immuno-Rheumatology Research Group, Hospital La Paz Institute for Health Research-IdiPAZ, Rheumatology, La Paz University Hospital, Madrid, Spain, 5ImmunoRheumatology Department, IDIPAZ, Madrid, Spain, 6Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain

    Background/Purpose: 1) to evaluate the relationship among adipose tissue dysfunction, autoimmunity and disease activity in rheumatoid arthritis (RA) patients; 2) to analyze the direct effect…
  • Abstract Number: 0032 • ACR Convergence 2021

    IL-40: A New B-cell Associated Cytokine Up-regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates with Disease Activity, Autoantibodies and NETosis

    Adela Navratilova1, Lucie Andrés Cerezo1, Hana Hulejová2, Viktor Bečvář2, Michal Tomcik3, Dana Tegzova2, Martina Olejárová1, David Veigl4, Karel Pavelka3, Jiri Vencovsky2 and Ladislav Senolt3, 1Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 2Institute of Rheumatology, Prague, Czech Republic, 3Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 4First Orthopaedic Clinic, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: Interleukin 40 (IL-40) is recently identified B cell - associated cytokine implicated in humoral immune responses and in B cell development and homeostasis. As…
  • Abstract Number: 0030 • ACR Convergence 2021

    Interleukin-9 Enhances the Osteoclastogenesis in Rheumatoid Arthritis

    Santanu Kar1, Dipendra Mitra2, Vijay Kumar D1 and Sushmita Chakraborty1, 1AIIMS, New Delhi, India, 2ALL INDIAN INSTITUTE OF MEDICAL SCIENCES, New Delhi, India

    Background/Purpose: Rheumatoid Arthritis (RA) is a chronic inflammatory disease characterized by synovial inflammation leading to bone destruction. Bone erosion in RA results from excessive resorption…
  • Abstract Number: 0034 • ACR Convergence 2021

    Immune Complexes Contain Novel Acetylated Antigens in the Synovial Fluid of RA Patients

    Khetam Ghannam1, Holger Bang2, Thomas Häupl1, Eugen Feist3 and Gerd Burmester4, 1Charite University Medicine Berlin, Berlin, Germany, 2Orgentec Diagnostika GmbH, Mainz, Germany, Mainz, Germany, 3Helios Department of Rheumatology, Vogelsang-Gommern, Germany, 4Charité University Medicine Berlin, Berlin, Germany

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterized by genetic predisposition and associated immunological features including the production of autoantibodies against various epitopes. Several…
  • Abstract Number: 0036 • ACR Convergence 2021

    The NAD+ Metabolism Is Altered in Rheumatoid Arthritis and Its Modulation with NAD+ Boosters Exhibits Key Anti-Inflammatory and Anti-Oxidant Effects

    Carlos Pérez-Sánchez1, Luz Marina Sanchez-Mendoza2, Nuria Barbarroja3, M.Carmen Abalos-Aguilera4, Maria Luque-Tevar5, Alejandra Patiño-Trives5, Iván Arias de la Rosa3, Cristobal Román-Rodriguez6, Juan Antonio Moreno2, Maria Isabel Buron2, Jose Antonio Gonzalez-Reyes2, Marta Rojas-Gimenez4, Eduardo Collantes-Estevez6, alejandro Escudero6, Jose Manuel Villalba2 and Chary lopez-pedrera6, 1IMIBIC, Córdoba, Spain, 2Department of Cell Biology, Physiology and Immunology, University of Córdoba, Campus de Excelencia Internacional Agroalimentario, ceiA3, Cordoba, Spain, 3University of Cordoba/IMIBIC/Reina Sofia Hospital, Cordoba, Spain, 4Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Córdoba, Cordoba, Spain, 5Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain, 6IMIBIC/Reina Sofia Hospital/University of Córdoba, Córdoba, Spain

    Background/Purpose: NAD+ is a key cofactor and second messenger for multiple cellular processes that exhibits antioxidant, anti-apoptotic, and anti-inflammatory properties. Numerous publications and clinical trials…
  • Abstract Number: 0035 • ACR Convergence 2021

    Bromodomain Protein-regulated Stress Response in Rheumatoid Arthritis Synovial Fibroblasts

    Tanja Seifritz1, Thomas Züllig1, Larissa Moser1, Oliver Distler2, Caroline Ospelt1 and Kerstin Klein3, 1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 2Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich/University of Zurich, Zurich, Switzerland, 3Department of Rheumatology and Immunology, University Hospital Bern, Bern, Switzerland

    Background/Purpose: Hypoxia and subsequent oxidative stress are early events in the RA joint and contribute to the activation of synovial fibroblasts (SF). Small molecule inhibitors…
  • Abstract Number: 0031 • ACR Convergence 2021

    A New Pharmacostatistical Model to Assess MTX-adherence in RA Patients

    Marion Geoffroy1, Claire Gozalo2, Loic Pauvele2, Elise Abboud2, Zoubir Djerada3 and Jean hugues Salmon4, 1CHU Reims, France, REIMS, France, 2CHU Reims, Reims, France, 3CHU Riems, Reims, France, 4Rheumatology, CHU Maison blanche, Reims, Reims, France

    Background/Purpose: Methotrexate (MTX) is the first-line therapy for rheumatoid arthritis (RA). While therapeutic adherence is essential to the successful management of the patient, an estimated…
  • Abstract Number: 0025 • ACR Convergence 2021

    The Modulatory Capacity of Galectin-3 on the Programmed Death-1 Signaling Axis in Rheumatoid Arthritis

    Kathrine Pedersen1, Morten Aagaard Nielsen2, Malene Hvid1, Bent Deleuran1 and Stinne Greisen1, 1Aarhus University, Aarhus, Denmark, 2Aarhus University / Aarhus University Hopital, Aarhus, Denmark

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation of the synovium. Despite a variety of treatments, 30-40% of RA patients fail…
  • « Previous Page
  • 1
  • …
  • 552
  • 553
  • 554
  • 555
  • 556
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology